Glyburide and Pigmentation disorder - a phase IV clinical study of FDA data

Summary:

Pigmentation disorder is reported as a side effect among people who take Glyburide (glyburide), especially for people who are female, 60+ old, also take Aspirin, and have Blood glucose abnormal.

The phase IV clinical study analyzes which people have Pigmentation disorder when taking Glyburide. It is created by eHealthMe based on reports of 37,840 people who have side effects when taking Glyburide from the FDA, and is updated regularly.

What is Glyburide?

Glyburide has active ingredients of glyburide. It is often used in diabetes. eHealthMe is studying from 38,448 Glyburide users. Check the latest studies of Glyburide.

What is Pigmentation disorder?

Pigmentation disorder (disturbances of human skin colour) is found to be associated with 640 drugs and 773 conditions by eHealthMe. Check the latest studies of Pigmentation disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

37,840 people reported to have side effects when taking Glyburide.
Among them, 17 people (0.04%) have Pigmentation disorder.

Could Glyburide cause Pigmentation disorder?

Among these 17 people:

What is the gender of people who have Pigmentation disorder when taking Glyburide? *

female: 64.71 %
male: 35.29 %

What is the age of people who have Pigmentation disorder when taking Glyburide? *

What are other drugs people take besides Glyburide? *

What are other side effects people have besides Pigmentation disorder? *

Rashes (redness): 7 people, 41.18%
Itching: 6 people, 35.29%
Weakness: 5 people, 29.41%
Dizziness: 5 people, 29.41%
Insomnia (sleeplessness): 4 people, 23.53%
Headache (pain in head): 4 people, 23.53%
Chest Pain: 3 people, 17.65%
Joint Pain: 3 people, 17.65%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 17.65%
Memory Loss: 3 people, 17.65%

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 2 people, 11.76%
Pain: 2 people, 11.76%
Herpes Zoster: 2 people, 11.76%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 11.76%
Breast Cancer: 2 people, 11.76%
Blood Pressure Abnormal: 2 people, 11.76%
Blood Glucose Abnormal: 2 people, 11.76%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.88%
Prostate Cancer: 1 person, 5.88%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Glyburide and have Pigmentation disorder?

- Check whether Pigmentation disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glyburide:

Glyburide (38,448 reports)

Browse all side effects of Glyburide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pigmentation disorder:

Pigmentation disorder (640 drugs)

Browse all the conditions that are associated with Pigmentation disorder:

Pigmentation disorder (773 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glyburide (the active ingredients of Glyburide) and Glyburide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.